These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9933091)

  • 21. Expression of complement regulating factors in gastric cancer cells.
    Inoue T; Yamakawa M; Takahashi T
    Mol Pathol; 2002 Jun; 55(3):193-9. PubMed ID: 12032231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement-regulatory proteins in ovarian malignancies.
    Bjørge L; Hakulinen J; Wahlström T; Matre R; Meri S
    Int J Cancer; 1997 Jan; 70(1):14-25. PubMed ID: 8985085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. bFGF and VEGF synergistically enhance endothelial cytoprotection via decay-accelerating factor induction.
    Mason JC; Lidington EA; Ahmad SR; Haskard DO
    Am J Physiol Cell Physiol; 2002 Mar; 282(3):C578-87. PubMed ID: 11832343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rat T cells express neither CD55 nor CD59 and are dependent on Crry for protection from homologous complement.
    Hanna S; Spiller O; Linton SM; Mead RJ; Morgan B
    Eur J Immunol; 2002 Feb; 32(2):502-9. PubMed ID: 11828367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the complement regulatory proteins decay accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46) and CD59 in the normal human uterine cervix and in premalignant and malignant cervical disease.
    Simpson KL; Jones A; Norman S; Holmes CH
    Am J Pathol; 1997 Nov; 151(5):1455-67. PubMed ID: 9358772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential expression of complement regulatory proteins decay-accelerating factor (CD55), membrane cofactor protein (CD46) and CD59 during human spermatogenesis.
    Simpson KL; Holmes CH
    Immunology; 1994 Mar; 81(3):452-61. PubMed ID: 7515850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55).
    Holmes CH; Simpson KL; Okada H; Okada N; Wainwright SD; Purcell DF; Houlihan JM
    Eur J Immunol; 1992 Jun; 22(6):1579-85. PubMed ID: 1376264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement expression on astrocytes and astrocytoma cell lines: failure of complement regulation at the C3 level correlates with very low CD55 expression.
    Spiller OB; Moretto G; Kim SU; Morgan BP; Devine DV
    J Neuroimmunol; 1996 Dec; 71(1-2):97-106. PubMed ID: 8982108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of the complement regulatory proteins CD46, CD55, and CD59 in human fallopian tube, endometrium, and cervical mucosa and secretion.
    Jensen TS; Bjørge L; Wollen AL; Ulstein M
    Am J Reprod Immunol; 1995 Jul; 34(1):1-9. PubMed ID: 7576125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro.
    Geis N; Zell S; Rutz R; Li W; Giese T; Mamidi S; Schultz S; Kirschfink M
    Curr Cancer Drug Targets; 2010 Dec; 10(8):922-31. PubMed ID: 20879979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relative roles of decay-accelerating factor, membrane cofactor protein, and CD59 in the protection of human endothelial cells against complement-mediated lysis.
    Brooimans RA; van Wieringen PA; van Es LA; Daha MR
    Eur J Immunol; 1992 Dec; 22(12):3135-40. PubMed ID: 1280224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokines modulate expression of cell-membrane complement inhibitory proteins in human lung cancer cell lines.
    Varsano S; Rashkovsky L; Shapiro H; Radnay J
    Am J Respir Cell Mol Biol; 1998 Sep; 19(3):522-9. PubMed ID: 9730881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Membrane complement regulatory proteins: insight from animal studies and relevance to human diseases.
    Miwa T; Song WC
    Int Immunopharmacol; 2001 Mar; 1(3):445-59. PubMed ID: 11367529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of decay-accelerating factor by cytokines or the membrane-attack complex protects vascular endothelial cells against complement deposition.
    Mason JC; Yarwood H; Sugars K; Morgan BP; Davies KA; Haskard DO
    Blood; 1999 Sep; 94(5):1673-82. PubMed ID: 10477692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant expression of membrane cofactor protein and decay-accelerating factor in the endothelium of patients with systemic sclerosis. A possible mechanism of vascular damage.
    Venneker GT; van den Hoogen FH; Boerbooms AM; Bos JD; Asghar SS
    Lab Invest; 1994 Jun; 70(6):830-5. PubMed ID: 7516986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complement regulatory proteins in early human fetal life: CD59, membrane co-factor protein (MCP) and decay-accelerating factor (DAF) are differentially expressed in the developing liver.
    Simpson KL; Houlihan JM; Holmes CH
    Immunology; 1993 Oct; 80(2):183-90. PubMed ID: 7505254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The expression of the complement regulators CD46, CD55, and CD59 by human sperm does not protect them from antisperm antibody- and complement-mediated immune injury.
    D'Cruz OJ; Haas GG
    Fertil Steril; 1993 Apr; 59(4):876-84. PubMed ID: 7681414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand interaction: modulation by cytokines.
    Arnold R; Seifert M; Asadullah K; Volk HD
    J Immunol; 1999 Jun; 162(12):7140-7. PubMed ID: 10358159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of complement regulatory proteins [membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59)] in endometrial stressed cells.
    Iborra A; Mayorga M; Llobet N; Martínez P
    Cell Immunol; 2003 May; 223(1):46-51. PubMed ID: 12914757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. K562 erythroleukemic cells are equipped with multiple mechanisms of resistance to lysis by complement.
    Jurianz K; Ziegler S; Donin N; Reiter Y; Fishelson Z; Kirschfink M
    Int J Cancer; 2001 Sep; 93(6):848-54. PubMed ID: 11519047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.